Purification and Structural Determination of Nontoxic Lipid A Obtained from the Lipopolysaccharide of Salmonella Typhimurium
Overview
Authors
Affiliations
Endotoxin extracted from the heptose-less mutant of Salmonella typhimurium was hydrolyzed in 0.1 N HCl in methanol/water (1:1, v/v) at 100 degrees C to yield lipid A, which was then fractionated on a Sephadex LH-20 column to yield a major monophosphoryl lipid A fraction. The monophosphoryl lipid A was further fractionated by preparative thin layer chromatography. This process yielded three major bands (TLC-1, -3, and -5) and two minor bands (TLC-7 and -9). The purity of these fractions was established by ion exchange and reverse phase high performance liquid chromatography. The thin layer fractions were analyzed by fast atom bombardment mass spectrometry. TLC-1 and -3 gave molecular ions (M-H)- at m/e 1730 and 1716, respectively. Both of these fractions contained beta-hydroxymyristic, lauric, and 3-myristoxymyristic acids in O-acyl linkages. The molecular formula and Mr of TLC-1 are C95H179O22N2P and 1731.16; those of TLC-3 are C94H177O22N2P and 1717.15. TLC-1 was a methyl homolog of TLC-3. The major component of TLC-5 (C80H151O22N2P and Mr = 1506.99) gave a molecular ion at m/e 1506 and contained two beta-hydroxymyristic acids and a lauric acid in the O-acyl linkages. The major component of TLC-7 (C66H125O19N2P and Mr = 1280.83) and the single component of TLC-9 gave molecular ions at m/e 1280 and 1098, respectively. TLC-7 contained lauric and beta-hydroxymyristic acids in the O-acyl linkages. TLC-9 (C54H103O18N2P and Mr = 1098.69) contained a single O-acylated beta-hydroxymyristate group. TLC-1 and -3 were nontoxic in the chick embryo lethality test and regressed established tumors in the syngeneic guinea pigs.
Ajam-Hosseini M, Akhoondi F, Parvini F, Fahimi H Front Cell Infect Microbiol. 2024; 13:1305510.
PMID: 38983695 PMC: 11232669. DOI: 10.3389/fcimb.2023.1305510.
Wang G, Wang Y, Ma F Cell Biosci. 2024; 14(1):24.
PMID: 38368397 PMC: 10874560. DOI: 10.1186/s13578-024-01207-7.
Trained immunity: a cutting edge approach for designing novel vaccines against parasitic diseases?.
Zhu J, Liu J, Yan C, Wang D, Pan W Front Immunol. 2023; 14:1252554.
PMID: 37868995 PMC: 10587610. DOI: 10.3389/fimmu.2023.1252554.
Genito C, Brooks K, Smith A, Ryan E, Soto K, Li Y NPJ Vaccines. 2023; 8(1):114.
PMID: 37563255 PMC: 10415390. DOI: 10.1038/s41541-023-00714-x.
Qureshi N, Desousa J, Siddiqui A, Drees B, Morrison D, Qureshi A Int J Mol Sci. 2023; 24(3).
PMID: 36769056 PMC: 9916932. DOI: 10.3390/ijms24032732.